In discussions with multiple potential animal health company partners to expand the indication and commercialize Canalevia ...
Clinical Trials Arena on MSN
Trials to watch: Three major catalysts in Alzheimer’s disease
While Lilly and Eisai/Biogen have validated the amyloid theory, there is an unmet need for drugs with alternative mechanisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback